BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10353323)

  • 1. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus.
    Ruiz C; Alegría A; Barberá R; Farré R; Lagarda MJ
    Scand J Clin Lab Invest; 1999 Apr; 59(2):99-105. PubMed ID: 10353323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation products.
    Djordjevic A; Spasic S; Jovanovic-Galovic A; Djordjevic R; Grubor-Lajsic G
    J Matern Fetal Neonatal Med; 2004 Dec; 16(6):367-72. PubMed ID: 15621558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum markers of oxidative stress and severity of diabetic retinopathy.
    Hartnett ME; Stratton RD; Browne RW; Rosner BA; Lanham RJ; Armstrong D
    Diabetes Care; 2000 Feb; 23(2):234-40. PubMed ID: 10868837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus.
    Whiting PH; Kalansooriya A; Holbrook I; Haddad F; Jennings PE
    Br J Biomed Sci; 2008; 65(2):71-4. PubMed ID: 19055108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.
    Kesavulu MM; Rao BK; Giri R; Vijaya J; Subramanyam G; Apparao C
    Diabetes Res Clin Pract; 2001 Jul; 53(1):33-9. PubMed ID: 11378211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma TBARS, blood GSH concentrations, and erythrocyte antioxidant enzyme activities in regularly menstruating women with ovulatory and anovulatory menstrual cycles.
    Lutosławska G; Tkaczyk J; Panczenko-Kresowska B; Hübner-Woźniak E; Skierska E; Gajewski AK
    Clin Chim Acta; 2003 May; 331(1-2):159-63. PubMed ID: 12691877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of smoking on plasma and erythrocyte antioxidant defense systems.
    Durak I; Yalçin S; Burak Cimen MY; Büyükkoçak S; Kaçmaz M; Oztürk HS
    J Toxicol Environ Health A; 1999 Mar; 56(6):373-8. PubMed ID: 10096360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pentylenetetrazol-induced epileptic seizure on the antioxidant enzyme activities, glutathione and lipid peroxidation levels in rat erythrocytes and liver tissues.
    Akbas SH; Yegin A; Ozben T
    Clin Biochem; 2005 Nov; 38(11):1009-14. PubMed ID: 16122723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus.
    Akkuş I; Kalak S; Vural H; Caglayan O; Menekşe E; Can G; Durmuş B
    Clin Chim Acta; 1996 Jan; 244(2):221-7. PubMed ID: 8714439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in glucose-6-phosphate dehydrogenase, copper, zinc-superoxide dismutase and catalase activities, glutathione and its metabolizing enzymes, and lipid peroxidation in rat erythrocytes with age.
    Oztürk O; Gümüşlü S
    Exp Gerontol; 2004 Feb; 39(2):211-6. PubMed ID: 15036414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated lipid peroxidation and disturbed antioxidant enzyme activities in plasma and erythrocytes of patients with uterine cervicitis and myoma.
    Chiou JF; Hu ML
    Clin Biochem; 1999 Apr; 32(3):189-92. PubMed ID: 10383079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity.
    Bandeira Sde M; Guedes Gda S; da Fonseca LJ; Pires AS; Gelain DP; Moreira JC; Rabelo LA; Vasconcelos SM; Goulart MO
    Oxid Med Cell Longev; 2012; 2012():819310. PubMed ID: 23259029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and benign breast disease patients evaluated in relation to oxidative stress.
    Seven A; Erbil Y; Seven R; Inci F; Gülyaşar T; Barutçu B; Candan G
    Cancer Biochem Biophys; 1998 Nov; 16(4):333-45. PubMed ID: 9925281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of antioxidant and lipid peroxidation in type 2 diabetic human subjects diagnosed with and without metabolic syndrome by using NCEP-ATPIII, IDF and WHO criteria.
    Yadav D; Mishra M; Joseph AZ; Subramani SK; Mahajan S; Singh N; Bisen PS; Prasad GB
    Obes Res Clin Pract; 2015; 9(2):158-67. PubMed ID: 25890429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus.
    Turk HM; Sevinc A; Camci C; Cigli A; Buyukberber S; Savli H; Bayraktar N
    Acta Diabetol; 2002 Sep; 39(3):117-22. PubMed ID: 12357295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
    Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
    J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus.
    Anderson RA; Roussel AM; Zouari N; Mahjoub S; Matheau JM; Kerkeni A
    J Am Coll Nutr; 2001 Jun; 20(3):212-8. PubMed ID: 11444416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects.
    Efe H; Değer O; Kirci D; Karahan SC; Orem A; Calapoğlu M
    Clin Chim Acta; 1999 Jan; 279(1-2):155-65. PubMed ID: 10064127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte antioxidant enzyme activities and lipid peroxidation in patients with types IIb and IV hyperlipoproteinemias.
    Efe H; Kirci D; Deger O; Yildirmis S; Uydu HA; Orem C
    Tohoku J Exp Med; 2004 Mar; 202(3):163-72. PubMed ID: 15065642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.